This cell line is phenotypically rich, amenable to genetic manipulation, and genetically engineered to resemble human melanoma through activated Braf and deactivated Pten and Cdkn2a (Fig. 1A; Meeth et al. 2016). This evidence concerns the gene CDKN2A and melanoma.